Alibaba Health Information Technology (241N) Ratios
Alibaba Health Information Technology Ratios
MX:241N's free cash flow for Q4 2026 was $679.19M. For the 2026 fiscal year, MX:241N's free cash flow was increased by $6.03M and operating cash flow was $791.00M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.03 | 2.59 | 2.69 | 2.74 | 2.81 |
| Quick Ratio | 2.66 | 2.29 | 2.41 | 2.36 | 2.49 |
| Cash Ratio | 1.13 | 0.47 | 0.69 | 2.01 | 2.19 |
| Solvency Ratio | 0.38 | 0.31 | 0.18 | 0.10 | -0.04 |
| Operating Cash Flow Ratio | 0.24 | 0.29 | 0.21 | 0.05 | 0.09 |
| Short-Term Operating Cash Flow Coverage | 41.95 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 10.15B | $ 7.41B | $ 8.32B | $ 9.31B | $ 8.44B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.29 | 1.30 | 1.35 | 1.37 | 1.36 |
| Debt Service Coverage Ratio | 36.61 | 571.95 | 157.95 | -6.68 | -52.83 |
| Interest Coverage Ratio | 1357.38 | 604.09 | 120.19 | -5.45 | -287.93 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Net Debt to EBITDA | -3.87 | -1.35 | -3.41 | 442.84 | 55.35 |
| Profitability Margins | |||||
| Gross Profit Margin | 23.97% | 24.29% | 21.81% | 21.30% | 19.96% |
| EBIT Margin | 4.13% | 5.11% | 3.50% | -0.19% | -1.21% |
| EBITDA Margin | 4.28% | 5.30% | 3.70% | -0.09% | -0.91% |
| Operating Profit Margin | 5.36% | 5.15% | 2.65% | -0.12% | -5.34% |
| Pretax Profit Margin | 6.64% | 5.10% | 3.48% | 2.06% | -1.23% |
| Net Profit Margin | 5.65% | 4.68% | 3.27% | 2.00% | -1.29% |
| Continuous Operations Profit Margin | 5.65% | 4.68% | 3.27% | 2.00% | -1.29% |
| Net Income Per EBT | 85.14% | 91.82% | 94.05% | 97.22% | 105.16% |
| EBT Per EBIT | 123.86% | 98.98% | 130.94% | -1733.39% | 22.99% |
| Return on Assets (ROA) | 8.41% | 6.76% | 4.48% | 2.58% | -1.38% |
| Return on Equity (ROE) | 10.88% | 8.78% | 6.07% | 3.53% | -1.88% |
| Return on Capital Employed (ROCE) | 10.24% | 9.59% | 4.89% | -0.21% | -7.64% |
| Return on Invested Capital (ROIC) | 8.70% | 8.80% | 4.58% | -0.20% | -7.63% |
| Return on Tangible Assets | 8.82% | 7.13% | 4.75% | 2.73% | -1.47% |
| Earnings Yield | 2.92% | 2.03% | 2.21% | 0.80% | -0.48% |
| Efficiency Ratios | |||||
| Receivables Turnover | 27.15 | 14.76 | 14.14 | 46.24 | 39.88 |
| Payables Turnover | 8.63 | 8.12 | 6.31 | 5.67 | 4.67 |
| Inventory Turnover | 14.14 | 16.37 | 15.10 | 10.02 | 10.62 |
| Fixed Asset Turnover | 392.25 | 438.87 | 260.71 | 390.43 | 124.63 |
| Asset Turnover | 1.49 | 1.44 | 1.37 | 1.29 | 1.07 |
| Working Capital Turnover Ratio | 3.84 | 3.82 | 3.01 | 2.94 | 2.11 |
| Cash Conversion Cycle | -3.05 | 2.09 | -7.89 | -20.04 | -34.69 |
| Days of Sales Outstanding | 13.44 | 24.73 | 25.81 | 7.89 | 9.15 |
| Days of Inventory Outstanding | 25.82 | 22.30 | 24.18 | 36.43 | 34.35 |
| Days of Payables Outstanding | 42.32 | 44.94 | 57.87 | 64.36 | 78.20 |
| Operating Cycle | 39.27 | 47.03 | 49.99 | 44.33 | 43.51 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.08 | 0.09 | 0.08 | 0.02 | 0.03 |
| Free Cash Flow Per Share | 0.08 | 0.09 | 0.08 | 0.02 | 0.03 |
| Dividend Paid and CapEx Coverage Ratio | 137.60 | 73.80 | 47.40 | 45.56 | 28.42 |
| Capital Expenditure Coverage Ratio | 137.60 | 73.80 | 47.40 | 45.56 | 28.42 |
| Operating Cash Flow Coverage Ratio | 20.76 | 39.28 | 13.14 | 3.29 | 3.13 |
| Operating Cash Flow to Sales Ratio | 0.04 | 0.05 | 0.04 | 0.01 | 0.02 |
| Free Cash Flow Yield | 1.85% | 1.95% | 2.65% | 0.37% | 0.74% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 34.15 | 49.28 | 45.22 | 125.22 | -208.70 |
| Price-to-Sales (P/S) Ratio | 1.94 | 2.31 | 1.48 | 2.51 | 2.69 |
| Price-to-Book (P/B) Ratio | 3.73 | 4.33 | 2.75 | 4.42 | 3.93 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 54.08 | 51.28 | 37.80 | 268.20 | 135.36 |
| Price-to-Operating Cash Flow Ratio | 53.69 | 50.59 | 37.00 | 262.32 | 130.60 |
| Price-to-Earnings Growth (PEG) Ratio | 0.98 | 1.17 | 0.78 | -0.42 | 1.19 |
| Enterprise Value Multiple | 41.40 | 42.21 | 36.58 | -2297.36 | -239.26 |
| Enterprise Value | 60.72B | 68.39B | 36.55B | 56.23B | 45.01B |
| EV to EBITDA | 41.40 | 42.21 | 36.58 | -2297.36 | -239.26 |
| EV to Sales | 1.77 | 2.23 | 1.35 | 2.10 | 2.19 |
| EV to Free Cash Flow | 49.46 | 49.69 | 34.57 | 224.86 | 109.93 |
| EV to Operating Cash Flow | 49.10 | 49.02 | 33.84 | 219.92 | 106.06 |
| Tangible Book Value Per Share | 1.03 | 0.95 | 0.95 | 1.04 | 0.96 |
| Shareholders’ Equity Per Share | 1.10 | 1.02 | 1.03 | 1.12 | 1.05 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.15 | 0.08 | 0.06 | 0.03 | -0.05 |
| Revenue Per Share | 2.11 | 1.90 | 1.92 | 1.98 | 1.53 |
| Net Income Per Share | 0.12 | 0.09 | 0.06 | 0.04 | -0.02 |
| Tax Burden | 0.85 | 0.92 | 0.94 | 0.97 | 1.05 |
| Interest Burden | 1.61 | 1.00 | 0.99 | -10.70 | 1.02 |
| Research & Development to Revenue | 0.02 | 0.02 | 0.03 | 0.03 | 0.04 |
| SG&A to Revenue | 0.08 | 0.09 | 0.01 | 0.01 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 |
| Income Quality | 0.64 | 0.89 | 1.15 | 0.48 | -1.60 |
Currency in CNY
